D. Salemović

发表

CMV DNA in blood and CSF of HIV infected patients.

M. Stanojevic, S. Žerjav, D. Jevtović, 2002, Virus research.

Intravenous drug use – an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients

M. Stanojevic, I. Pešić-Pavlović, B. Brmbolić, 2017, Archives of medical science : AMS.

Treatment outcome of HAART-treated patients in a resource-limited setting: the Belgrade Cohort Study.

J. Marinkovic, O. Djurković-Djaković, D. Salemović, 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

HIV-1 resistance profile in plasma and peripheral blood lymphocytes in a group of naive patients

M. Stanojevic, V. Nikolić, I. Pešić-Pavlović, 2012 .

The prognosis of highly active antiretroviral therapy (HAART) treated HIV infected patients in Serbia, related to the time of treatment initiation.

B. Brmbolić, O. Dulović, D. Salemović, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The prognosis of patients with dissociated virological and immunological responses to HAART

D. Salemović, D. Jevtović, J. Ranin, 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The Prognosis of Late Presenters in the Era of Highly Active Antiretroviral Therapy in Serbia

I. Pešić-Pavlović, B. Brmbolić, S. Žerjav, 2009, The open virology journal.

The prognosis of CMV retinitis among patients with AIDS in Serbia.

B. Brmbolić, O. Djurković-Djaković, D. Salemović, 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.

I. Pešić, S. Žerjav, O. Djurković-Djaković, 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The dissociation between virological and immunological responses to HAART.

I. Pešić, S. Žerjav, O. Djurković-Djaković, 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The increasing prevalence of HIV / Helicobacter pylori co-infection over time , along with the evolution of ART Authors

Z. Bukumirić, Z. Stojsić, I. Pešić-Pavlović, 2017 .

The increasing prevalence of HIV/Helicobacter pylori co-infection over time, along with the evolution of antiretroviral therapy (ART)

Z. Bukumirić, Z. Stojsić, I. Pešić-Pavlović, 2017, PeerJ.

Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.

M. Stanojevic, V. Nikolić, I. Pešić-Pavlović, 2014, AIDS research and human retroviruses.

The prevalence and risk of immune restoration disease in HIV‐infected patients treated with highly active antiretroviral therapy

I. Pešić, S. Žerjav, O. Djurković-Djaković, 2005, HIV medicine.

Clinical and Immunologic Outcomes of HAART-Treated HIV-Infected Women in Resource Constrain Settings: The Belgrade Study

J. Nikolić, D. Jevtović, D. Salemović, 2014, Women & health.

HIV infection and Cushing's disease

M. Stojanovic, M. Žarković, J. Ciric, 2014 .

Syphilitic alopecia in HIV infected homosexual men: case reports.

S. Šipetić, M. Bjekić, D. Salemović, 2012, Acta dermatovenerologica Croatica : ADC.

Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphoma.

B. Mihaljević, D. Jevtović, D. Salemović, 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

HIV-1 subtype B spread through cross-border clusters in the Balkans: a molecular analysis in view of incidence trends

M. Poljak, E. Kostaki, D. Otelea, 2022, AIDS.

Molecular typing of the local HIV-1 epidemic in Serbia.

M. Stanojevic, V. Nikolić, I. Pešić-Pavlović, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study.

M. Stanojevic, I. Boricic, B. Brmbolić, 2018, Current HIV research.

The treatment outcome of chronic HBV infection among HBV/HIV co-infected and HBV mono-infected patients

Uroš Karić, I. Pešić-Pavlović, I. Milošević, 2019, International journal of STD & AIDS.

Comparison of Nucleoside Reverse Transcriptase Inhibitor Use as Part of First-Line Therapy in a Serbian and a UK HIV Clinic

M. Youle, M. Johnson, D. Jevtović, 2009, HIV clinical trials.

Exploring Evolutionary and Transmission Dynamics of HIV Epidemic in Serbia: Bridging Socio-Demographic With Phylogenetic Approach

M. Stanojevic, V. Ćirković, I. Pešić-Pavlović, 2019, Front. Microbiol..

Forensic application of phylogenetic analyses - Exploration of suspected HIV-1 transmission case.

S. Nikolić, M. Stanojevic, V. Ćirković, 2017, Forensic science international. Genetics.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Tracing the origin and dynamics of the HIV-1 epidemic in Serbia

M. Stanojevic, V. Nikolić, I. Pešić-Pavlović, 2014 .

High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia

M. Stanojevic, V. Ćirković, I. Pešić-Pavlović, 2017, Intervirology.

Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

A. Horban, J. Tomažič, R. Matulionytė, 2020, HIV medicine.

The metabolic syndrome, an epidemic among HIV-infected patients on HAART.

O. Djurković-Djaković, D. Salemović, G. Dragović, 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

PRIMARY HIV-1 RESISTANCE - PERSISTENCE OF TRANSMITTED DRUG RESISTANCE MUTATIONS

M. Stanojevic, V. Nikolić, I. Pešić-Pavlović, 2012 .

Human papillomavirus and anal carcinoma knowledge in men who have sex with men in Belgrade, Serbia

H. Vlajinac, S. Šipetić-Grujičić, M. Bjekić, 2016, International journal of dermatology.

Diagnostic esophago-gastro-duodenoscopy (EGD) in patients with AIDS-related upper gastrointestinal abnormalities.

J. Nikolić, Z. Stojsić, M. Korac, 2009, Hepato-gastroenterology.

Helicobacter pylori infection rates in dyspeptic Serbian HIV-infected patients compared to HIV-negative controls

Z. Bukumirić, M. Korac, B. Brmbolić, 2021, PloS one.

Isoniazid-resistant Mycobacterium kansasii in an HIV-positive patient, and possible development of immune reconstitution inflammatory syndrome after initiation of highly active antiretroviral therapy: case report.

B. Savić, D. Salemović, J. Ranin, 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

HIV-1 subtypes in Yugoslavia.

T. Jovanović, A. Papa, M. Stanojevic, 2002, AIDS research and human retroviruses.

The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.

M. Veselinovic, E. Stefanova, D. Salemović, 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Jan Albert, Kirsi Liitsola, Mario Poljak, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The prognosis of pediatric AIDS in serbia.

B. Brmbolić, O. Djurković-Djaković, D. Salemović, 2009, Current HIV research.